Headlight

Headlight's Portland clinic specializes in Spravato (esketamine) nasal spray therapy, an FDA-approved treatment for treatment-resistant depression. This innovative approach offers hope to patients who have not responded adequately to traditional antidepressants.

Beyond Spravato therapy, Headlight provides comprehensive mental health services including individual therapy, psychiatric evaluations, and personalized medication management. Their integrated treatment model combines cutting-edge pharmaceutical interventions with evidence-based therapeutic approaches, addressing both biological and psychological aspects of mental health.

Headlight is committed to making quality mental health care accessible to Portland residents. They accept most major insurance plans and work with patients to navigate coverage options, ensuring financial barriers do not prevent individuals from receiving needed treatment.